Compositions and methods for using CA9 protein to stimulate an immune response
Provided are methods for stimulating an immune response to an antigen by administering a composition to an individual in an amount effective to stimulate an immune response to the antigen. The stimulated immune response to the antigen is greater than the immune response stimulated by the antigen in the absence of CA9 protein. The compositions provided contain a complex that includes an antigen and an isolated CA9 protein.
1. A method for stimulating an immune response against an antigen in an individual, the method comprising administering to the individual a composition comprising a complex of isolated carbonic anhydrase IX (CA9) protein and an antigen, wherein the antigen is not a heat shock protein, wherein the administration of the composition stimulates an immune response against the antigen that is greater than an immune response stimulated by a composition comprising the antigen but not comprising the isolated CA9 protein.
2. The method of claim 1 , wherein the complex is formed at a temperature between 30° C. and 42° C., inclusive.
3. The method of claim 1 , wherein the complex is formed at 37° C.
4. The method of claim 1 , wherein the antigen is a tumor antigen.
5. The method of claim 4 , wherein the tumor antigen and the isolated CA9 protein are present in a complex formed by mixing the isolated CA9 protein with a tumor lysate.
6. The method of claim 1 , wherein the composition further comprises antigen presenting cells that have been contacted with the complex prior to administration to the individual.
7. The method of claim 1 , wherein the immune response against the antigen stimulated by administration of the complex comprises a cell-mediated immune response against the antigen.
8. A composition comprising a complex of isolated carbonic anhydrase IX (CA9) protein and an antigen, wherein the antigen is not a heat shock protein, wherein the composition is capable of stimulating an immune response against the antigen, wherein the stimulated immune response is greater than an immune response stimulated by a composition comprising the antigen without CA9 protein, and wherein the composition comprises a carrier suitable for use in administering the composition to an individual in need of the stimulated immune response.
9. The composition of claim 8 , wherein the antigen is a tumor antigen.
10. The composition of claim 8 , further comprising antigen presenting cells.
11. A composition comprising a substantially purified population of dendritic cells that have been contacted with the composition of claim 8 .